176 related articles for article (PubMed ID: 28803677)
1. Indole-fused azepines and analogues as anticancer lead molecules: Privileged findings and future directions.
Singh AK; Raj V; Saha S
Eur J Med Chem; 2017 Dec; 142():244-265. PubMed ID: 28803677
[TBL] [Abstract][Full Text] [Related]
2. FeCl
Shiva Kumar K; Siddi Ramulu M; Rajesham B; Kumar NP; Voora V; Kancha RK
Org Biomol Chem; 2017 May; 15(20):4468-4476. PubMed ID: 28497830
[TBL] [Abstract][Full Text] [Related]
3. Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents.
Patil SA; Patil R; Miller DD
Future Med Chem; 2012 Oct; 4(16):2085-115. PubMed ID: 23157240
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of novel anti-proliferative pyrroloazepinone and indoloazepinone oximes derived from the marine natural product hymenialdisine.
White AW; Carpenter N; Lottin JR; McClelland RA; Nicholson RI
Eur J Med Chem; 2012 Oct; 56():246-53. PubMed ID: 22995819
[TBL] [Abstract][Full Text] [Related]
5. Thee-component, one-pot synthesis of hexahydroazepino[3,4-b]indole and tetrahydro-1H-pyrido[3,4-b]indole derivatives and evaluation of their cytotoxicity.
Reddy BVS; Venkata Ganesh A; Vani M; Ramalinga Murthy T; Kalivendi SV; Yadav JS
Bioorg Med Chem Lett; 2014 Sep; 24(18):4501-4503. PubMed ID: 25176193
[TBL] [Abstract][Full Text] [Related]
6. Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents, an update (2013-2015).
Patil R; Patil SA; Beaman KD; Patil SA
Future Med Chem; 2016 Jul; 8(11):1291-316. PubMed ID: 27476704
[TBL] [Abstract][Full Text] [Related]
7. Indole RSK inhibitors. Part 1: discovery and initial SAR.
Boyer SJ; Burke J; Guo X; Kirrane TM; Snow RJ; Zhang Y; Sarko C; Soleymanzadeh L; Swinamer A; Westbrook J; Dicapua F; Padyana A; Cogan D; Gao A; Xiong Z; Madwed JB; Kashem M; Kugler S; O'Neill MM
Bioorg Med Chem Lett; 2012 Jan; 22(1):733-7. PubMed ID: 22100312
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and antiproliferative activity of a novel class of indole-2-carboxylate derivatives.
Ji XY; Xue ST; Zhan YC; Shen JJ; Wu LT; Jin J; Wang Z; Li ZR
Eur J Med Chem; 2014 Aug; 83():409-18. PubMed ID: 24996136
[TBL] [Abstract][Full Text] [Related]
9. Solvent-free, microwave assisted Knoevenagel condensation of novel 2,5-disubstituted indole analogues and their biological evaluation.
Biradar JS; Sasidhar BS
Eur J Med Chem; 2011 Dec; 46(12):6112-8. PubMed ID: 22014995
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Anticancer Chemotherapeutics based upon Azepine Scaffold.
Singh S; Goo J; Gajulapati V; Chang TS; Lee K; Choi Y
Anticancer Agents Med Chem; 2016; 16(5):539-57. PubMed ID: 26373395
[TBL] [Abstract][Full Text] [Related]
11. Pyrrolo[2,3-c]azepine derivatives: a new class of potent protein tyrosine phosphatase 1B inhibitors.
Xie J; Tian J; Su L; Huang M; Zhu X; Ye F; Wan Y
Bioorg Med Chem Lett; 2011 Jul; 21(14):4306-9. PubMed ID: 21696953
[TBL] [Abstract][Full Text] [Related]
12. First generation design, synthesis, and evaluation of azepine-based cryptophycin analogues.
Smith AB; Cho YS; Zawacki LE; Hirschmann R; Pettit GR
Org Lett; 2001 Dec; 3(25):4063-6. PubMed ID: 11735585
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of isomeric methoxy substitutions on anti-cancer indolyl-pyridinyl-propenones: Effects on potency and mode of activity.
Trabbic CJ; George SM; Alexander EM; Du S; Offenbacher JM; Crissman EJ; Overmeyer JH; Maltese WA; Erhardt PW
Eur J Med Chem; 2016 Oct; 122():79-91. PubMed ID: 27343855
[TBL] [Abstract][Full Text] [Related]
14. Cyclohepta[b]indoles: A Privileged Structure Motif in Natural Products and Drug Design.
Stempel E; Gaich T
Acc Chem Res; 2016 Nov; 49(11):2390-2402. PubMed ID: 27709885
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, anticancer activity, and SAR analyses of compounds containing the 5:7-fused 4,6,8-triaminoimidazo[4,5-e][1,3]diazepine ring system.
Xie M; Lapidus RG; Sadowska M; Edelman MJ; Hosmane RS
Bioorg Med Chem; 2016 Jun; 24(12):2595-602. PubMed ID: 27134120
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and anticancer activities of hybrids of indole and barbituric acids--identification of highly promising leads.
Singh P; Kaur M; Verma P
Bioorg Med Chem Lett; 2009 Jun; 19(11):3054-8. PubMed ID: 19398334
[TBL] [Abstract][Full Text] [Related]
17. Structure-based drug design and potent anti-cancer activity of tricyclic 5:7:5-fused diimidazo[4,5-d:4',5'-f][1,3]diazepines.
Kondaskar A; Kondaskar S; Fishbein JC; Carter-Cooper BA; Lapidus RG; Sadowska M; Edelman MJ; Hosmane RS
Bioorg Med Chem; 2013 Feb; 21(3):618-31. PubMed ID: 23290252
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of new securinine analogues as potential anticancer agents.
Perez M; Ayad T; Maillos P; Poughon V; Fahy J; Ratovelomanana-Vidal V
Eur J Med Chem; 2016 Feb; 109():287-93. PubMed ID: 26793989
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and preliminary evaluation of 3-thiocyanato-1H-indoles as potential anticancer agents.
Fortes MP; da Silva PB; da Silva TG; Kaufman TS; Militão GC; Silveira CC
Eur J Med Chem; 2016 Aug; 118():21-6. PubMed ID: 27116711
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and evaluation of 3,4-dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-ones as inhibitors of poly(ADP-ribose) polymerase.
Tikhe JG; Webber SE; Hostomsky Z; Maegley KA; Ekkers A; Li J; Yu XH; Almassy RJ; Kumpf RA; Boritzki TJ; Zhang C; Calabrese CR; Curtin NJ; Kyle S; Thomas HD; Wang LZ; Calvert AH; Golding BT; Griffin RJ; Newell DR
J Med Chem; 2004 Oct; 47(22):5467-81. PubMed ID: 15481984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
